Latest filing published 17 Jul 2026 for Adma Biologics, INC..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Terry Kohler: trading record in brief
Terry Kohler is a declared insider at 3 companies; the most frequent names are Verrica Pharmaceuticals Inc., OptiNose, Inc. and Adma Biologics, Inc. Over a trading history stretching from 24 August 2023 to 16 July 2026, the count stands at 11 filings.
No open-market purchase appears, only 4 sales worth €146k. Besides market trades, the filings include 6 share grants.
The record was last updated on 17 July 2026 with a share grant in Adma Biologics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Terry Kohler
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 85,130 shares0Common StockSEC:0001140361-26-028844:0
- 30,541 sharesCommon StockSEC:0001104659-25-051349:0
- 13,875 shares0Common StockSEC:0001494650-25-000011:0
- 125,000 shares0Common StockSEC:0001415889-25-003233:0
- 150,000 shares0Common StockSEC:0001494650-24-000145:0
- 21,820 shares@ US$2.6650.7% of flowCommon StockSEC:0001415889-24-022424:0
- 40,000 shares0Common StockSEC:0001415889-24-008541:0
- 18,452 shares@ US$2.9349.3% of flowCommon StockSEC:0001209191-23-055531:0
- 62,500 shares0Common StockSEC:0001209191-23-047524:0
9 of 9 declarations
